Joan Bevilacqua

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age.

G. Dayan, J. Bevilacqua, G. Risi, 2012, Vaccine.

Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.

M. Watson, G. Dayan, Rex Biedenbender, 2011, The Journal of infectious diseases.

Diphtheria and tetanus immunity among blood donors in Toronto.

J. Thipphawong, L. Yuan, W. Lau, 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data.

L. Coudeville, P. André, F. Bailleux, 2008, Vaccine.

Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

T. Monath, J. Lang, G. Dayan, 2013, Viruses.